In 2020, Lars Fruergaard Jørgensen was the highest-paid top executive among Denmark's elite companies. It's hard to strike the right balance, says the Novo Nordisk Chair.
Chair of the Novo Nordisk Board Helge Lund thinks tax payers will be paying a large bill for the Covid-19 crisis. He also expects an additional pressure to fall on the pharmaceutical industry in future years.
Denmark wishes to establish a Covid-19 research fund with Israel and Austria and explore the possibility of a joint vaccine production with the two countries, according to the parties at a press conference.